A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease

Clinical trial NCT03462121 · COMPLETED

Trial details

NCT number: NCT03462121
Sponsor: Regenera Pharma Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mild to Moderate Dementia Due to Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease

Start date: 2018-03-01
Primary completion: 2019-12-28
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.